Tower Research Capital (TRC)’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.9K Buy
4,226
+1,227
+41% +$4.91K ﹤0.01% 3770
2025
Q1
$9.54K Sell
2,999
-10,823
-78% -$34.4K ﹤0.01% 3763
2024
Q4
$73.9K Buy
+13,822
New +$73.9K ﹤0.01% 2334
2024
Q3
Sell
-15,300
Closed -$27.8K 5742
2024
Q2
$27.8K Buy
15,300
+3,789
+33% +$6.9K ﹤0.01% 3544
2024
Q1
$20.5K Buy
11,511
+3,008
+35% +$5.35K ﹤0.01% 2981
2023
Q4
$15K Sell
8,503
-16,234
-66% -$28.6K ﹤0.01% 3846
2023
Q3
$36.1K Buy
24,737
+4,194
+20% +$6.12K ﹤0.01% 2851
2023
Q2
$47K Buy
20,543
+7,946
+63% +$18.2K ﹤0.01% 2614
2023
Q1
$11K Sell
12,597
-121
-1% -$106 ﹤0.01% 4196
2022
Q4
$11K Buy
12,718
+1,050
+9% +$908 ﹤0.01% 3799
2022
Q3
$10K Buy
11,668
+2,335
+25% +$2K ﹤0.01% 4518
2022
Q2
$9K Buy
9,333
+6,361
+214% +$6.13K ﹤0.01% 4542
2022
Q1
$5K Sell
2,972
-14,592
-83% -$24.5K ﹤0.01% 5035
2021
Q4
$42K Sell
17,564
-3,635
-17% -$8.69K ﹤0.01% 2898
2021
Q3
$102K Buy
21,199
+13,545
+177% +$65.2K ﹤0.01% 2384
2021
Q2
$20K Sell
7,654
-35,132
-82% -$91.8K ﹤0.01% 3875
2021
Q1
$132K Buy
42,786
+41,890
+4,675% +$129K ﹤0.01% 2347
2020
Q4
$3K Sell
896
-5,554
-86% -$18.6K ﹤0.01% 4784
2020
Q3
$26K Buy
6,450
+4,596
+248% +$18.5K ﹤0.01% 3772
2020
Q2
$5K Buy
1,854
+1,654
+827% +$4.46K ﹤0.01% 4264
2020
Q1
$0 Buy
+200
New ﹤0.01% 3163
2019
Q4
Sell
-2,147
Closed -$6K 3663
2019
Q3
$6K Buy
+2,147
New +$6K ﹤0.01% 3207
2019
Q2
Sell
-408
Closed -$2K 3767
2019
Q1
$2K Sell
408
-10,402
-96% -$51K ﹤0.01% 3388
2018
Q4
$40K Buy
10,810
+9,140
+547% +$33.8K ﹤0.01% 1428
2018
Q3
$14K Buy
1,670
+137
+9% +$1.15K ﹤0.01% 2549
2018
Q2
$17K Sell
1,533
-2,100
-58% -$23.3K ﹤0.01% 2518
2018
Q1
$42K Buy
3,633
+2,114
+139% +$24.4K ﹤0.01% 1768
2017
Q4
$16K Sell
1,519
-748
-33% -$7.88K ﹤0.01% 2219
2017
Q3
$37K Sell
2,267
-4,304
-65% -$70.2K ﹤0.01% 2241
2017
Q2
$80K Buy
+6,571
New +$80K 0.01% 566
2017
Q1
Sell
-1,427
Closed -$21K 3174
2016
Q4
$21K Buy
+1,427
New +$21K ﹤0.01% 2080
2016
Q3
Sell
-3,455
Closed -$49K 3741
2016
Q2
$49K Buy
3,455
+411
+14% +$5.83K ﹤0.01% 1565
2016
Q1
$44K Buy
+3,044
New +$44K 0.01% 841